Originally published Sept 8, 2023
By Sarah McLeod, M.S., Regulatory Analyst/Medical Writer
Next-generation sequencing (NGS) assays provide a clinically valid resource for precision medicine. Knowing how NGS assays perform on different regions of a chromosome with different genetic variants helps to determine the benefit of these tests for specific patient groups. This article offers a bulleted list of clinical performance evaluators by which to analyze published clinical trials. Get the article here.